Patient with agammaglobulinemia produces anti-SARS-CoV-2 reactive T-cells after CoronaVac vaccine
Sign Up to like & getrecommendations! Published in 2022 at "Clinics"
DOI: 10.1016/j.clinsp.2022.100007
Abstract: Since the first case of COVID-19, at the end of 2019, SARS-CoV-2 has spread rapidly worlwide, causing the death of more than 5 million people to this date and profoundly impacting population lifestyles. Clinical manifestations… read more here.
Keywords: sars cov; agammaglobulinemia produces; agammaglobulinemia; immune response ... See more keywords